Millions of asthma patients across the UK are being urged to avoid overusing their blue 'reliever' inhalers, following government warnings that excessive use could paradoxically trigger more severe attacks. The alert affects the 5.4 million Britons living with asthma, many of whom rely on salbutamol inhalers during breathing difficulties.
Blue inhalers, which work by opening the airways to ease breathing, are designed for occasional use during asthma symptoms. However, frequent overuse can lead to medication dependency and may actually worsen symptoms over time, creating a dangerous cycle for patients.
A Department of Health and Social Care spokesperson emphasised: "It's essential that patients follow the medication guidelines provided by their healthcare professionals carefully. This will help to manage their symptoms effectively and reduce the risk of severe asthma attacks."
The guidance forms part of broader government efforts to improve asthma management across the UK. According to Asthma UK, the condition affects over 5.4 million people nationally, with many more at risk of developing asthma in future.
Shadow Health Secretary Wes Streeting welcomed the reminder, stating: "This is a timely reminder of the importance of proper asthma management. We need to ensure that patients have access to the right treatment and support to manage their symptoms effectively."
The warning coincides with a new government awareness campaign designed to educate both patients and healthcare professionals about proper inhaler use and the risks of over-reliance on reliever medications.